Skip to content

CapEx at other companies

Pfizer logo
PfizerPFE
$436M-22.7%
CG Oncology logo
CG OncologyCGON
$304K+1,800%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0-100%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$353K+132%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0-100%
Erasca, Inc. logo
Erasca, Inc.ERAS
$36K-56.6%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s capex?
Oric Pharmaceuticals, Inc. (ORIC) reported capex of $2K in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s capex changed year-over-year?
Oric Pharmaceuticals, Inc.'s capex decreased by 99.5% year-over-year, from $387K to $2K.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s capex?
Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s capex has grown at a -6.7% compound annual growth rate (CAGR), from $939K to $712K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.